CELG.RT

Bristol-Myers Squibb Company Contingent Value Rights

22 hedge funds and large institutions have $57.2K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change